Lawsuit Launched Against Cannabis Companies for Mislabeling

Are cannabis companies purposefully misleading consumers about THC and CBD content? A new lawsuit filed in Canada highlights this trend. The class-action claim against fifteen major players in the cannabis sector alleges that THC and CBD levels in their products do not match their labels. What’s worse – in some cases the mislabeling is intentional. If successful, the $500-million-plus lawsuit will require these companies to pay out consumers who bought their products dating back to 2016 as repayment for poor quality control standards. It could deal a powerful blow to the cannabis industry as a whole, one that could sink the entire ship by undermining public confidence. Or, it could function like a prescribed burn, clearing out the dead ways of doing business so more ethical operations can grow. Only time will tell which happens. Not the First Time While the lawsuit’s allegations have not been proven in court, this is not the first time cannabis companies have come under fire for mislabeling their goods. In fact, this quality assurance problem has become a perennial issue, with new reports and allegations fired off like clockwork. A 2017 study1)Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. 318(17):1708–1709. doi:10.1001/jama.2017.11909 jQuery(“#footnote_plugin_tooltip_7761_1”).tooltip({ tip: “#footnote_plugin_tooltip_text_7761_1”, tipClass: “footnote_tooltip”, effect: “fade”, fadeOutSpeed: 100, predelay: 400, position: “top right”, relative: true, offset: [10, 10] }); published in the Journal of the American Medical Association found nearly seventy percent of all CBD product sold online in the United States…

Excerpt only …
READ MORE BELOW
Source : rxleaf
Link to original : Lawsuit Launched Against Cannabis Companies for Mislabeling
reposted by Cannabis News World